News
NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...
2d
Cryptopolitan on MSNOpenEden and Ceffu Launch First Yield-Bearing Collateral on MirrorRSVInstitutional clients can use cUSDO, OpenEden Digital’s yield-bearing digital asset, as collateral on MirrorRSV while ...
NAVAL, Biliran (PIA) — The provincial office of the Bureau of Fire Protection (BFP) in Biliran has inaugurated its newly completed rappelling facility on June 26, marking a significant milestone in ...
NAVAL, Biliran (PIA) — The P28.9 million major repair of the Biliran Bridge, a vital infrastructure linking Biliran Island to ...
For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...
In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...
13d
Offshore Technology on MSNBrazil’s Petrobras unveils plans for $6bn refinery improvementsThe planned investments include 29bn reais in Petrobras CapEx and an additional 4bn reais in a project that operates with ...
10d
Woman's World on MSNSneaky COPD Symptoms Every Woman Over 50 Should KnowChronic obstructive pulmonary disease (COPD) is a lung condition that often hides in plain sight. You may think you're ...
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...
Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results